Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor A Yayon, M Klagsbrun, JD Esko, P Leder, DM Ornitz Cell 64 (4), 841-848, 1991 | 3102 | 1991 |
Heparan sulphate proteoglycans fine-tune mammalian physiology JR Bishop, M Schuksz, JD Esko Nature 446 (7139), 1030-1037, 2007 | 1920 | 2007 |
Order out of chaos: assembly of ligand binding sites in heparan sulfate JD Esko, SB Selleck Annual review of biochemistry 71 (1), 435-471, 2002 | 1817 | 2002 |
The sweet and sour of cancer: glycans as novel therapeutic targets MM Fuster, JD Esko Nature Reviews Cancer 5 (7), 526-542, 2005 | 1630 | 2005 |
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate Y Chen, T Maguire, RE Hileman, JR Fromm, JD Esko, RJ Linhardt, ... Nature medicine 3 (8), 866-871, 1997 | 1383 | 1997 |
A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry D Shukla, J Liu, P Blaiklock, NW Shworak, X Bai, JD Esko, GH Cohen, ... Cell 99 (1), 13-22, 1999 | 1281 | 1999 |
Molecular diversity of heparan sulfate JD Esko, U Lindahl The Journal of clinical investigation 108 (2), 169-173, 2001 | 1171 | 2001 |
Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. MT Shieh, D WuDunn, RI Montgomery, JD Esko, PG Spear The Journal of cell biology 116 (5), 1273-1281, 1992 | 775 | 1992 |
Animal cell mutants defective in glycosaminoglycan biosynthesis. JD Esko, TE Stewart, WH Taylor Proceedings of the National Academy of Sciences 82 (10), 3197-3201, 1985 | 723 | 1985 |
Microbial adherence to and invasion through proteoglycans KS Rostand, JD Esko Infection and immunity 65 (1), 1-8, 1997 | 607 | 1997 |
Endothelial heparan sulfate deficiency impairs L-selectin-and chemokine-mediated neutrophil trafficking during inflammatory responses L Wang, M Fuster, P Sriramarao, JD Esko Nature immunology 6 (9), 902-910, 2005 | 606 | 2005 |
Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice X Lin, G Wei, Z Shi, L Dryer, JD Esko, DE Wells, MM Matzuk Developmental biology 224 (2), 299-311, 2000 | 533 | 2000 |
Heparin’s anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins L Wang, JR Brown, A Varki, JD Esko The Journal of clinical investigation 110 (1), 127-136, 2002 | 510 | 2002 |
A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate … K Lidholt, JL Weinke, CS Kiser, FN Lugemwa, KJ Bame, S Cheifetz, ... Proceedings of the National Academy of Sciences 89 (6), 2267-2271, 1992 | 346 | 1992 |
Multiple isozymes of heparan sulfate/heparin GlcNAcN-deacetylase/GlcN N-sulfotransferase: structure and activity of the fourth member, NDST4 J Aikawa, K Grobe, M Tsujimoto, JD Esko Journal of Biological Chemistry 276 (8), 5876-5882, 2001 | 309 | 2001 |
Mice deficient in Ext2 lack heparan sulfate and develop exostoses D Stickens, BM Zak, N Rougier, JD Esko, Z Werb Oxford University Press for The Company of Biologists Limited 132 (22), 5055 …, 2005 | 298 | 2005 |
Influence of core protein sequence on glycosaminoglycan assembly JD Esko, L Zhang Current opinion in structural biology 6 (5), 663-670, 1996 | 284 | 1996 |
Tumor formation dependent on proteoglycan biosynthesis JD Esko, KS Rostand, JL Weinke Science 241 (4869), 1092-1096, 1988 | 255 | 1988 |
Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members JM MacArthur, JR Bishop, KI Stanford, L Wang, A Bensadoun, JL Witztum, ... The Journal of clinical investigation 117 (1), 153-164, 2007 | 249 | 2007 |
Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Gal beta 1--> 4GlcNAc beta-O-naphthalenemethanol. AK Sarkar, TA Fritz, WH Taylor, JD Esko Proceedings of the National Academy of Sciences 92 (8), 3323-3327, 1995 | 248 | 1995 |